Vocabria is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Cabotegravir Sodium.
Product ID | 49702-248_65b02f5b-063a-4832-b1ec-ada39ea0e66e |
NDC | 49702-248 |
Product Type | Human Prescription Drug |
Proprietary Name | Vocabria |
Generic Name | Cabotegravir Sodium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2021-01-21 |
Marketing Category | NDA / NDA |
Application Number | NDA212887 |
Labeler Name | ViiV Healthcare Company |
Substance Name | CABOTEGRAVIR SODIUM |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-01-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() VOCABRIA 87420842 5335230 Live/Registered |
ViiV Healthcare UK (No.3) Limited 2017-04-21 |